Table 2.
Distribution of neuropsychiatric comorbidities in the asthma and control groups (n, %)
| Psychiatric comorbidities | Asthma group (n = 261) | Control group (n = 261) | χ2 | P |
|---|---|---|---|---|
| Attention deficit hyperactivity disorder | 30(11.5) | 12(4.6) | 8.389 | 0.004 |
| Inattentive type | 18(6.9) | 8(3.1) | ||
| Combined type | 9(3.4) | 3(1.1) | ||
| Hyperactive impulsive | 3(1.1) | 1(0.4) | ||
| Oppositional defiant disorder | 28(10.7) | 15(5.7) | 4.283 | 0.038 |
| Separation anxiety disorder | 16(6.1) | 6(2.3) | 4.745 | 0.029 |
| Social anxiety disorder | 10(3.8) | 8(3.1) | 0.230 | 0.631 |
| Specific phobia | 6(2.3) | 3(1.1) | 0.452 | 0.501a |
| Agoraphobia without panic | 4(1.5) | 1(0.4) | 0.808 | 0.369a |
| (Mild) manic episodesc | 3(1.1) | 0(0.0) | 0.249b | |
| Major depressive episode | 2(0.8) | 0(0.0) | 0.499b | |
| Tic disorder | 2(0.8) | 0(0.0) | 0.499b | |
| Dysthymia | 1(0.4) | 0(0.0) | 1.000b |
acontinuous correction chi-squared test, bFisher’s exact test, cA manic episode is defined in the American Psychiatric Association’s Diagnostic Manual (DSM-5) as a “distinct period of abnormally and persistently elevated, expansive, or irritable mood and abnormally and persistently increased activity or energy, lasting at least 1 week and present most of the day, nearly every day (or any duration if hospitalization is necessary)”